Literature DB >> 2469774

Stability of plasmid sequences in an acute Q-fever strain of Coxiella burnetii.

J E Samuel1, M E Frazier, L P Mallavia.   

Abstract

The rickettsial pathogen Coxiella burnetii undergoes a variation in which virulent isolates (phase 1) become avirulent (phase 2) after repeated passage in a non-immunologically competent host. Biochemically, this variation is associated with a lipopolysaccharide modification and possibly other factors. Genetically, the regions of DNA responsible for phase variation have not been identified. We have sought to determine whether the plasmid identified in acute disease isolates, QpH1, which represents approximately 5% of the coding capacity of this organism is involved in phase variation. Plasmids from phase 1 and phase 2 variants (designated QpH1 and QpH2, respectively) were compared by restriction endonuclease digestion and Southern blot hybridization to determine whether sequence changes in the phase 2 plasmid might account for changes in the virulence of phase 2 organisms compared with that of phase 1 cells. Using over 20 different restriction enzymes, no changes in DNA restriction fragment patterns were detected regardless of whether the phase change occurred during egg or tissue culture passage. The plasmid-specific mRNAs produced from metabolically active, purified cells were identical for each phase type. Using QpH1 or QpH2 DNA as a template, the mRNA produced by an E. coli extract was also identical. Finally, the proteins encoded by either plasmid in an in vitro transcription/translation reaction were identical. These data indicate that within the limits of our analysis, the plasmid DNA from C. burnetii phase variants is structurally and functionally the same and is therefore unlikely to be involved in phase variation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2469774     DOI: 10.1099/00221287-134-7-1795

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  10 in total

1.  Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction.

Authors:  A Stein; D Raoult
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.

Authors:  Guoquan Zhang; Ho To; Kasi E Russell; Laura R Hendrix; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai; James E Samuel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 3.  Molecular biology of rickettsiae.

Authors:  H H Winkler
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

4.  Study of the 16S-23S ribosomal DNA internal spacer of Coxiella burnetii.

Authors:  A Stein; D Kruszewska; J Gouvernet; D Raoult
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

5.  Transformation of Rochalimaea quintana, a member of the family Rickettsiaceae.

Authors:  D K Reschke; M E Frazier; L P Mallavia
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

Review 6.  Coxiella burnetii: international pathogen of mystery.

Authors:  Amanda L Dragan; Daniel E Voth
Journal:  Microbes Infect       Date:  2019-09-28       Impact factor: 2.700

Review 7.  Genetics of rickettsiae.

Authors:  L P Mallavia
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

8.  Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection.

Authors:  Andreas Stein; Céline Louveau; Hubert Lepidi; Fanny Ricci; Pascal Baylac; Bernard Davoust; Didier Raoult
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

9.  Analysis of the entire nucleotide sequence of the cryptic plasmid QpH1 from Coxiella burnetti.

Authors:  D Thiele; H Willems; M Haas; H Krauss
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

10.  Is plasmid based differentiation of Coxiella burnetii in 'acute' and 'chronic' isolates still valid?

Authors:  D Thiele; H Willems
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.